Maintenance and Improvement of Skin Clearance Response With Brodalumab Among Patients With Moderate-to-Severe Psoriasis

Main Article Content

Neal D Bhatia
Seemal R Desai
Craig Teller
Abby Jacobson


psoriasis, brodalumab


Abstract not available.


1. Siliq [package insert]. Valeant Pharmaceuticals North America LLC; 2017.

2. Strober et al. Poster presented at: 76th Annual Meeting of the American Academy of Dermatology; February 16-20, 2018; San Diego, CA.

3. Papp et al. Br J Dermatol. 2016;175:273-286.

Most read articles by the same author(s)

1 2 3 > >>